Glenn A. Eisenberg, Chief Financial Officer, EVP at LABORATORY CORP OF AMERICA HOLDINGS (LH), sold 69,008 shares at $217.98 ($14.9M) on 2024-02-21, disclosed to the SEC on 2024-02-22.
Seasonal sale ($14.9M) by Chief Financial Officer, EVP — this insider has traded LH in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $215.37 | 18,379 | $4.0M | 26.6% |
| 2 | $215.37 | 18,379 | $4.0M | 26.6% |
| 3 | $215.68 | 7,907 | $1.7M | 11.4% |
| 4 | $215.68 | 7,907 | $1.7M | 11.4% |
| 5 | $217.52 | 6,665 | $1.4M | 9.7% |
| 6 | $217.52 | 6,665 |
| $1.4M |
| 9.7% |
| 7 | $217.98 | 1,553 | $339K | 2.3% |
| 8 | $217.98 | 1,553 | $339K | 2.3% |
| Total | $215.97 avg | 69,008 | $14.9M | 100% |
| Filing → |
| LH | SELL | 2022-09-28 | $10.5M | — | Filing → |
| LH | SELL | 2022-08-05 | $15.9M | — | Filing → |
| LH | SELL | 2019-07-10 | $2.0M | — | Filing → |